Novartis India Ltd

AI
Novartis India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Novartis India Ltd

₹
- close price
novartis.in BSE: 500672 NSE: NOVARTIND
About

Novartis India Ltd is primarily engaged in the Business of Wholesale of pharmaceuticals and medical goods.
[1] It imports various medicines to India from different sources across the globe.[2]

Key Points

Business
The company is primarily engaged in the pharmaceutical business in the area of pain management, organ transplantation, neuroscience, etc. [1]

Website BSE NSE
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value ₹
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE Healthcare BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF
Upcoming result date: 3 November 2026

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow
Free Cash Flow
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit

Ratios
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of permanent employees
count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Related party (Novartis Pharma AG) purchases as % of total purchases
% ・Standalone data
Number of dealers/distributors
count ・Standalone data
Number of brands
count ・Standalone data
Single largest customer revenue concentration
% ・Standalone data
Top 10 dealers/distributors concentration
% ・Standalone data
Healthcare professionals reached
count ・Standalone data
Retail outlets covered
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68% 70.68%
0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.17% 0.16% 1.21%
0.52% 0.52% 0.52% 0.52% 0.53% 0.53% 0.53% 0.53% 0.63% 0.53% 1.35% 1.50%
28.60% 28.61% 28.60% 28.61% 28.60% 28.61% 28.60% 28.61% 28.50% 28.60% 27.81% 26.61%
No. of Shareholders 43,12841,23939,26539,59638,92639,13339,04039,35339,46838,11636,50238,127

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls